-
May 7, 2021 New Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says ExpertThere's new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama...
-
May 7, 2021 Psychedelic Business News Spotlight: May 7, 2021This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands...
-
May 6, 2021 NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, EsketamineNew treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine...
-
May 6, 2021 Ketamine Effectively Treats Persistent Migraine Headaches: StudyA nasal spray of ketamine proved to be highly effective at treating a type of...
-
May 6, 2021 MindMed’s Project Angie to Explore LSD for Chronic Pain TreatmentPsychedelic life sciences company MindMed is exploring LSD as a means of pain management.
-
May 5, 2021 Canada Approves New Leaf’s Bid to Build First-Of-Its-Kind Psilocybin LabNew Leaf Canada has received permission from Health Canada to build a first-of-its-kind laboratory to...
-
May 4, 2021 Psychedelic Companies Combine Forces to Create Virtual Reality ExperienceA new psychedelic VR experience is coming thanks to a partnership between Lobe Sciences and...
-
May 4, 2021 Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSDThe first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.
-
May 3, 2021 Researchers Discover Therapeutic Potential of Non-Hallucinogenic PsychedelicResearchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.
-
May 3, 2021 Former NFL Player Kerry Rhodes Discusses Ayahuasca Experience With Tamron HallActor and former NFL safety Kerry Rhodes says the psychedelic compound ayahuasca has helped him...
